Company Filing History:
Years Active: 2005-2025
Title: Michel Arnaud: Innovator in Immunology
Introduction
Michel Arnaud is a notable inventor based in Villeurbanne, France. He has made significant contributions to the field of immunology, particularly through his innovative patents. With a total of two patents to his name, Arnaud's work focuses on methods for detecting immune cellular responses and diagnosing rheumatoid polyarthritis.
Latest Patents
One of Michel Arnaud's latest patents is a method for detecting an immune cellular response. This method includes several steps, such as suctioning a defined amount of the sample using an automated device, discharging it into a container with or without a stimulant, and allowing the sample to incubate. The detection of the immune cellular response indicates the presence of a specific immune response for the stimulant.
His second patent involves antigens derived from filaggrin, which are used for diagnosing rheumatoid polyarthritis. This invention concerns an artificial antigen that is specifically identified by anti-filaggrin autoantibodies present in the serum of patients suffering from this condition. The antigen consists of a polypeptide that includes a sequence of a filaggrin unit, where an arginine radical has been substituted by a citrulline radical.
Career Highlights
Michel Arnaud is currently associated with bioMérieux, Inc., a company known for its expertise in diagnostics. His work at bioMérieux has allowed him to further his research and development in immunology, contributing to advancements in medical diagnostics.
Collaborations
Throughout his career, Michel has collaborated with esteemed colleagues such as Guy Serre and Elisabeth Girbal-Neuhauser. These collaborations have enriched his research and have led to significant advancements in the field.
Conclusion
Michel Arnaud's innovative work in immunology, particularly through his patents, showcases his dedication to advancing medical diagnostics. His contributions are vital in the ongoing efforts to improve the detection and diagnosis of immune-related conditions.